drugset / Trial / NCT00907322
A Phase 1 Trial To Assess The Safety And Pharmacokinetics Of Single, Ascending, Oral Doses Of Dimebon In Healthy Adults
RandomizedCrossoverDouble-blind
Summary
The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of Dimebon following single ascending doses. A formal single ascending dose study of this nature has not been performed to date in the Dimebon development program.
Timeline
- Start
- 2009-06
- Primary completion
- 2009-07
- Completion
- 2009-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Latrepirdine | Small molecule | 20 mg | Oral |
| Subject | Latrepirdine | Small molecule | 40 mg | Oral |
| Subject | Latrepirdine | Small molecule | 60 mg | Oral |
Indications
No indication recorded.